1. Home
  2. INDP vs UGRO Comparison

INDP vs UGRO Comparison

Compare INDP & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • UGRO
  • Stock Information
  • Founded
  • INDP 2000
  • UGRO 2014
  • Country
  • INDP United States
  • UGRO United States
  • Employees
  • INDP N/A
  • UGRO N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • UGRO Industrial Specialties
  • Sector
  • INDP Health Care
  • UGRO Consumer Discretionary
  • Exchange
  • INDP Nasdaq
  • UGRO Nasdaq
  • Market Cap
  • INDP 4.0M
  • UGRO 3.8M
  • IPO Year
  • INDP N/A
  • UGRO N/A
  • Fundamental
  • Price
  • INDP $2.60
  • UGRO $0.30
  • Analyst Decision
  • INDP Strong Buy
  • UGRO Strong Buy
  • Analyst Count
  • INDP 1
  • UGRO 1
  • Target Price
  • INDP $140.00
  • UGRO $3.00
  • AVG Volume (30 Days)
  • INDP 67.5K
  • UGRO 12.0M
  • Earning Date
  • INDP 11-07-2025
  • UGRO 10-30-2025
  • Dividend Yield
  • INDP N/A
  • UGRO N/A
  • EPS Growth
  • INDP N/A
  • UGRO N/A
  • EPS
  • INDP N/A
  • UGRO N/A
  • Revenue
  • INDP N/A
  • UGRO $59,985,138.00
  • Revenue This Year
  • INDP N/A
  • UGRO N/A
  • Revenue Next Year
  • INDP N/A
  • UGRO $28.40
  • P/E Ratio
  • INDP N/A
  • UGRO N/A
  • Revenue Growth
  • INDP N/A
  • UGRO N/A
  • 52 Week Low
  • INDP $2.22
  • UGRO $0.26
  • 52 Week High
  • INDP $47.60
  • UGRO $1.69
  • Technical
  • Relative Strength Index (RSI)
  • INDP 41.62
  • UGRO 36.45
  • Support Level
  • INDP $2.45
  • UGRO $0.29
  • Resistance Level
  • INDP $3.76
  • UGRO $0.32
  • Average True Range (ATR)
  • INDP 0.28
  • UGRO 0.03
  • MACD
  • INDP -0.05
  • UGRO -0.01
  • Stochastic Oscillator
  • INDP 30.63
  • UGRO 2.53

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Share on Social Networks: